OpGen Completes $17m Series B Financing

OpGen, Inc., a Maryland-based commercial phase genomics company, completed a $17 million Series B round of equity financing. The new round of financing was led by jVen Capital with participation from the company’s other major investors, including CHL Medical Partners, Highland Capital Partners, Mason Wells Biomedical and Versant Ventures. Evan Jones of jVen Capital has been named as executive chairman of OpGen’s boards.

North AmericaUSBriefs